Home > Publications Database > Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. > print

001     280942
005     20250907001942.0
024 7 _ |a 10.1038/s41392-025-02346-0
|2 doi
024 7 _ |a pmid:40887468
|2 pmid
024 7 _ |a 2095-9907
|2 ISSN
024 7 _ |a 2059-3635
|2 ISSN
024 7 _ |a altmetric:180886009
|2 altmetric
037 _ _ |a DZNE-2025-01025
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Herzog, Maximilian Jonathan
|b 0
245 _ _ |a Arterial stiffness and vascular aging: mechanisms, prevention, and therapy.
260 _ _ |a London
|c 2025
|b Macmillan Publishers, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756738504_32760
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Cardiovascular diseases are the leading cause of morbidity and mortality worldwide. The central underlying mechanisms of cardiovascular diseases are vascular aging and associated arterial stiffness. Arterial stiffness is characterized by structural (e.g., tunica media calcification, alterations in vascular smooth muscle cells, and fibrosis) and functional (e.g., loss of Windkessel function, elevated pulse pressure, and development of isolated systolic hypertension) vascular changes that cause microvascular dysfunction and end-organ damage (e.g., heart failure, vascular dementia, hypertensive retinopathy, and chronic kidney disease). Current research indicates that arterial stiffness is an independent risk factor for cardiovascular diseases and represents a potential target for personalized prevention and therapeutic approaches. In this review, we summarize the pathophysiological mechanisms of vascular aging and arterial stiffness, outline the resulting end-organ damage, present different methods for the measurement of arterial stiffness, highlight the potential role of prevention and therapy, and provide future perspectives for arterial stiffness research. The purpose of this review is to provide a state-of-the-art interdisciplinary and translational approach to arterial stiffness, highlighting unique pathophysiological mechanisms (e.g., perivascular adipose tissue, extracellular vesicles), clinical relevance, and future directions.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Vascular Stiffness: genetics
|2 MeSH
650 _ 2 |a Aging: pathology
|2 MeSH
650 _ 2 |a Cardiovascular Diseases: physiopathology
|2 MeSH
650 _ 2 |a Cardiovascular Diseases: therapy
|2 MeSH
650 _ 2 |a Cardiovascular Diseases: prevention & control
|2 MeSH
650 _ 2 |a Cardiovascular Diseases: pathology
|2 MeSH
650 _ 2 |a Muscle, Smooth, Vascular: pathology
|2 MeSH
650 _ 2 |a Muscle, Smooth, Vascular: metabolism
|2 MeSH
650 _ 2 |a Muscle, Smooth, Vascular: physiopathology
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
700 1 _ |a Müller, Patrick
|0 P:(DE-2719)2811487
|b 1
|e First author
|u dzne
700 1 _ |a Lechner, Katharina
|b 2
700 1 _ |a Stiebler, Marvin
|0 P:(DE-2719)9002212
|b 3
|u dzne
700 1 _ |a Arndt, Philipp
|0 P:(DE-2719)9000797
|b 4
|u dzne
700 1 _ |a Kunz, Matthias
|b 5
700 1 _ |a Ahrens, Dörte
|b 6
700 1 _ |a Schmeißer, Alexander
|b 7
700 1 _ |a Schreiber, Stefanie
|0 P:(DE-2719)2812631
|b 8
|u dzne
700 1 _ |a Braun-Dullaeus, Ruediger C
|b 9
773 _ _ |a 10.1038/s41392-025-02346-0
|g Vol. 10, no. 1, p. 282
|0 PERI:(DE-600)2886872-9
|n 1
|p 282
|t Signal transduction and targeted therapy
|v 10
|y 2025
|x 2095-9907
856 4 _ |u https://pub.dzne.de/record/280942/files/DZNE-2025-01025.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/280942/files/DZNE-2025-01025.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:280942
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811487
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-2719)9002212
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9000797
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2812631
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-17
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SIGNAL TRANSDUCT TAR : 2022
|d 2024-12-17
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b SIGNAL TRANSDUCT TAR : 2022
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:44:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:44:53Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-17
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:44:53Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
920 1 _ |0 I:(DE-2719)1310003
|k AG Müller
|l Neuroprotection
|x 0
920 1 _ |0 I:(DE-2719)1310010
|k AG Schreiber
|l Mixed Cerebral Pathologies and Cognitive Aging
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1310003
980 _ _ |a I:(DE-2719)1310010
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21